Delivery Order SPE2DR25D3301-SPE2DR26F20CW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $38,816.78 to AmerisourceBergen Drug Corp for the supply of Kengreal 50 mg vials. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, was awarded on a competitive basis without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a child order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Kengreal 50 mg vials, a pharmaceutical product used in acute coronary syndrome treatment. This firm fixed-price delivery order, valued at $5,673.24, is scheduled for completion by September 15, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $7,494.65 firm fixed price contract is for the supply of KENGREAL 50 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of July 15, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
- This federal contract award, valued at $12,389.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KENGREAL 50 MG VIALS, a medical product, and is a Firm Fixed Price Delivery Order with a completion date of February 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a $6,207.65 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of KENGREAL 50 MG VIALS, a specialized cardiovascular medication. The contract has an ultimate completion date of December 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,858.56 firm-fixed-price delivery order is for the supply of 4556791245 KENGREAL 50 MG VIALS, with an ultimate completion date of April 6, 2022. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a key vendor for federal healthcare programs, particularly within military and...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $14,678.52 placed under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the procurement of 4,565,563,515 vials of the medication KENGREAL 50 MG. This IDC, worth up to $999,999,999 and running through November 2026, serves as a primary vehicle for Amerisourcebergen to provide a...
- <p>The Defense Logistics Agency awarded a $43,248 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562100543 KENGREAL 50 MG VIALS. To be performed in Conshohocken, Pennsylvania from September 8-11, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order supports DLA's logistical requirements for specified drug products. No subcontractors or set aside designations were indicated.</p>
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,472.70 on December 29, 2025, for the supply of Kerendia 10 mg tablets (30-count packages). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,337.94 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Kerendia 10 mg on December 12, 2025, with an ultimate completion date of December 15, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to the company's corporate office location in...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F20CWDelivery Order
The Defense Logistics Agency awarded a $15,116.82 delivery order to AmerisourceBergen Drug Corp for the supply of Kengreal 50 mg vials, with a completion date of January 5, 2026. The contract employs firm fixed-price pricing and was awarded on January 2, 2026, without a set-aside designation, indicating competitive selection. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceuticals and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfilling delivery orders for diverse pharmaceutical products across multiple therapeutic domains in support of Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.1k | 1/1/26 |